Affinity Asset Advisors’s Mersana Therapeutics MRSN Stock Holding History

Affinity Asset Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.89M	Buy
2024 Q3	–	Sell
2024 Q2	$1.54M	Sell
2024 Q1	$4.48M	Hold
2023 Q4	$2.32M	Sell
2023 Q3	$3.62M	Buy
2021 Q3	–	Sell
2021 Q2	$1.15M	Hold
2021 Q1	$1.38M	Buy
2020 Q4	$1.33M	Buy